Welcome to JEmedis

JEmedis. Our Team. Our Mission.

JEmedis is a driven young business. Small, agile and, above all, innovative.

JEMEDIA ASCDMO

Contract Manufacturing at JEmedis

When it comes to process development, the analysis, or the production of your product – JEmedis is your reliable and competent CDMO

UROLOGICAL AND ONCOLOGICAL EXPERTISE

Our Product for Bladder Cancer Treatment 

Doxorubicin, the active ingredient of our product, is the first cytostatic pharmaceutical developed to prevent the recurrence of superficial bladder cancer. With this, JEmedis exclusively offers a bladder instillation set. JEmedis is also developing a further product for this therapeutic area.

You’re interested

in CDMO

(contract manufacturing)?

You’re interested in 

our products in the area of

der urology/oncology??

JEmedis GmbH is a pharmaceutical
company
born out of PharmaCept GmbH,
which focuses on two areas:

  • The sales and development of pharmaceuticals and other products in the field of urology/oncology

  • CDMO – specifically, in the process development and contract manufacturing of biologics

You’re interested

in CDMO

(contract manufacturing)?

You’re interested in 

our products in the area of

der urology/oncology??

JEmedis GmbH is a pharmaceutical
company
born out of PharmaCept GmbH,
which focuses on two areas:

  • The sales and development of pharmaceuticals and other products in the field of urology/oncology

  • CDMO – specifically, in the process development and contract manufacturing of biologics

Learn more about the JEmedis team, our mission and the history of our company.

Read about our proven medicine for the prevention of bladder cancer recurrence.

Find out how JEmedis can support you in the development of your own products.

You would like to discover more about JEmedis? We look forward to hearing from you and will get back to you as soon as possible.

JEmedis is a young pharmaceutical company that emerged from PharmaCept GmbH, which I had founded previously. JEmedis stands for a committed team with lean decision-making processes to facilitate quick and easy implementation. In our work, we combine innovative know-how with many years of experience.

Jürgen Ebert, MD

Founder and Managing Director of JEmedis